Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12610000323022
ACTRN12610000323022
Not Yet Recruiting
N/A

Intrathecal baclofen therapy for management of spasticity: An Australian paediatric multicentre prospective audit.

Princess Margaret Hospital for Children0 sites100 target enrollmentApril 21, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCerebral PalsySpinal Cord InjuryNeurological - Other neurological disorders

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cerebral Palsy
Sponsor
Princess Margaret Hospital for Children
Enrollment
100
Status
Not Yet Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 21, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Princess Margaret Hospital for Children

Eligibility Criteria

Inclusion Criteria

  • •Enrolment in this paediatric long term outcome audit will be offered to new patients offered ITB therapy.
  • •The decision whom is offered ITB therapy in Western Australia rests with Movement Disorder’s team at Princess Margaret Hospital. This decision is made following a multidisciplinary medical assessment process including a test dose of intrathecal baclofen.
  • •Hospitals providing paediatric ITB programmes in Australia include Princess Margaret Hospital for Children (Perth), Royal Childrens Hospital (Melbourne), Monash Medical Centre (Melbourne), Westmead Childrens Hospital (Sydney), Women \& Childrens Hospital (Adelaide) and the Royal Childrens Hospital (Brisbane).

Exclusion Criteria

  • •There are no specific exclusion criteria.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Phase 4
Intrathecal Baclofen therapy with the implanted pump system for Spastic Palsy (Post-marketing clinical trial extended phase 3 after NDA approval)[Spinal cord Origin] Spinal cord Injury, Multiple sclerosis, Spinocerebellar degeneration, Circulatory disorder of the spinal, Ossification of the posterior longitudinal ligament [Cerebral Origin] Cerebral palsy, Traumatic head injury
JPRN-jRCT1080220031DAIICHI SANKYO COMPANY, LIMITED
Completed
Phase 3
Dutch National ITB Study in Children With Cerebral PalsyCerebral PalsySpasticity
NCT00367068Maastricht University18
Completed
N/A
Intrathecal Baclofen Infusion for Reflex sympathetic Dystrophy related dystoniaReflex sympathetic dystrophy (RSD)Signs and SymptomsPain
ISRCTN43633981eiden University Medical Centre (LUMC) (The Netherlands)45
Completed
Phase 2
Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant SpasticityCerebral Palsy
NCT00221611University Hospital, Ghent80
Completed
N/A
The BIRD study. Intrathecal Baclofen Infusion for Reflex Sympathetic Dystrophy related dystonia.Reflex sympathetic dystrophy (RSD) related dystonia.
NL-OMON27484eiden University Medical Centre, Dept. of Neurology45